Ultragenyx Pharm (RARE)

The overall ratings of 41 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – CRDS MRNS IONS RSYS

By Portfolio Grader Jul 15, 2016

The following stocks were moving the Manufacturing sector today.

3 Stocks to Watch on Thursday: Monsanto Company (MON), Ultragenyx Pharmaceutical Inc (RARE) and Yum! Brands, Inc. (YUM)

By Karl Utermohlen, InvestorPlace Writer Jul 14, 2016

Yum Brands (YUM) beat second-quarter expectations, Monsanto (MON) looks to combine its agrochemical business with another company, and more.

22 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 11, 2016

This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

19 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 4, 2016

The overall ratings of 19 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

10 Biotech Stocks That Could Erupt Within Months

By James Brumley, InvestorPlace Feature Writer Jul 1, 2016

These biotech stocks have some major, potentially price-changing news lined up between now and the end of September.

Hottest Manufacturing Stocks Now – JAGX GBIM PRTK TROX

By Portfolio Grader Jun 17, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – CCXI AERI ONCE ICAD

By Portfolio Grader May 18, 2016

The following stocks were moving the Manufacturing sector today.

10 Biotech Stocks With Big Catalysts Coming This Quarter

By James Brumley, InvestorPlace Feature Writer Mar 31, 2016

Fans of binary trading events should find that these biotech stocks are well poised for big-time volatility over the course of the next several weeks.

Ultragenyx Pharm (RARE)

3 Genomics Stocks That May Transform Personalized Medicine

7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline

RARE Stock Earnings: Ultragenyx Pharmaceutical Misses EPS, Misses Revenue for Q1 2024

7 Biotech Stocks to Buy for Breakthrough Treatments and Cures

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Ultragenyx Pharm (RARE)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

RARE Stock Predictions, Articles, and Ultragenyx Pharm News

Subscriber Sign in